Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Thomas Tulip, President and Chief Business Officer, will participate at the Jefferies 2014 Global Healthcare Conference June 2-5, 2014 at the Grand Hyatt in New York City, NY. Dr. Tulip will present a Company update on Thursday, June 5, 2014 at 1:30 PM EDT.
Help employers find you! Check out all the jobs and post your resume.
